JP2024517027A5 - - Google Patents

Info

Publication number
JP2024517027A5
JP2024517027A5 JP2023569935A JP2023569935A JP2024517027A5 JP 2024517027 A5 JP2024517027 A5 JP 2024517027A5 JP 2023569935 A JP2023569935 A JP 2023569935A JP 2023569935 A JP2023569935 A JP 2023569935A JP 2024517027 A5 JP2024517027 A5 JP 2024517027A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
cdr
chain variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023569935A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024517027A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SG2022/050308 external-priority patent/WO2022240360A1/en
Publication of JP2024517027A publication Critical patent/JP2024517027A/ja
Publication of JP2024517027A5 publication Critical patent/JP2024517027A5/ja
Pending legal-status Critical Current

Links

JP2023569935A 2021-05-11 2022-05-11 キメラ抗原受容体及びそれを含む改変細胞 Pending JP2024517027A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG10202104940X 2021-05-11
SG10202104940X 2021-05-11
PCT/SG2022/050308 WO2022240360A1 (en) 2021-05-11 2022-05-11 Chimeric antigen receptors and modified cells comprising the same

Publications (2)

Publication Number Publication Date
JP2024517027A JP2024517027A (ja) 2024-04-18
JP2024517027A5 true JP2024517027A5 (cg-RX-API-DMAC7.html) 2025-05-19

Family

ID=84029911

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023569935A Pending JP2024517027A (ja) 2021-05-11 2022-05-11 キメラ抗原受容体及びそれを含む改変細胞

Country Status (9)

Country Link
US (1) US20240252536A1 (cg-RX-API-DMAC7.html)
EP (1) EP4337684A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024517027A (cg-RX-API-DMAC7.html)
KR (1) KR20240007204A (cg-RX-API-DMAC7.html)
CN (1) CN117616039A (cg-RX-API-DMAC7.html)
AU (1) AU2022271707A1 (cg-RX-API-DMAC7.html)
CA (1) CA3215528A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023013296A (cg-RX-API-DMAC7.html)
WO (1) WO2022240360A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116322785A (zh) 2020-07-20 2023-06-23 德卡生物科学公司 包含il-10的双细胞因子融合蛋白
AU2023225954A1 (en) 2022-02-22 2024-09-05 Deka Biosciences, Inc. Method of reducing bispecific t cell engager or chimeric antigen receptor t cell mediated cytokine release syndrome using interleukins
WO2024128219A1 (ja) * 2022-12-13 2024-06-20 愛知県 キメラ抗原受容体
CN116874596B (zh) * 2023-09-06 2023-11-24 南京佰抗生物科技有限公司 抗S100β蛋白的单克隆抗体及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018057585A1 (en) * 2016-09-21 2018-03-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Chimeric antigen receptor (car) that targets chemokine receptor ccr4 and its use
US11788093B2 (en) * 2017-09-07 2023-10-17 University Of Florida Research Foundation, Inc. Chimeric antigen receptor t-cells expressing interleukin-8 receptor
EP3766977A4 (en) * 2018-03-16 2021-12-08 Shinshu University GENETICALLY MODIFIED CELL AND METHOD FOR MANUFACTURING IT
US12441787B2 (en) * 2018-04-02 2025-10-14 National University Of Singapore Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
EP3781176A4 (en) * 2018-04-09 2022-05-25 The Trustees of the University of Pennsylvania METHODS AND COMPOSITIONS USING A VIRAL VECTOR FOR THE EXPRESSION OF A TRANSGENE AND AN EFFECTOR
KR102088789B1 (ko) * 2018-06-20 2020-03-13 인하대학교 산학협력단 항 TNF/IFN scFv-Fc 이중 표적 항체 및 이의 이용
US20250302959A1 (en) * 2022-05-24 2025-10-02 Leibniz-Institut Für Immuntherapie (Lit) Artificial immune receptors
CN118005804A (zh) * 2024-01-29 2024-05-10 北京医院 一种响应致炎细胞因子的CAR序列和CAR-Treg细胞的构建方法及应用

Similar Documents

Publication Publication Date Title
JP2022523781A5 (cg-RX-API-DMAC7.html)
JP2019516352A5 (cg-RX-API-DMAC7.html)
JP2020513839A5 (cg-RX-API-DMAC7.html)
AU2017301880C1 (en) Immunomodulatory polypeptides and related compositions and methods
JP2021000103A5 (cg-RX-API-DMAC7.html)
JP2022530773A5 (cg-RX-API-DMAC7.html)
HRP20221348T1 (hr) Kimerni receptori i postupci njihove uporabe
HRP20251135T1 (hr) Postupci dobivanja kimernih stanica koje eksprimiraju antigenske receptore
CA3111087A1 (en) Anti-mesothelin chimeric antigen receptor (car) constructs and uses thereof
JP2021530233A5 (cg-RX-API-DMAC7.html)
JP2019515661A5 (cg-RX-API-DMAC7.html)
CA3032054A1 (en) Combination therapies of chimeric antigen receptors and pd-1 inhibitors
JP2017524367A5 (cg-RX-API-DMAC7.html)
JP2023518930A5 (cg-RX-API-DMAC7.html)
RU2019128921A (ru) Антитело к il-13ra2 и его применение
US20240067955A1 (en) Methods for high throughput screening of chimeric antigen receptors
JP2024539506A5 (cg-RX-API-DMAC7.html)
JP2022538425A5 (cg-RX-API-DMAC7.html)
JP2025511409A5 (cg-RX-API-DMAC7.html)
JP2025513427A5 (cg-RX-API-DMAC7.html)
WO2021127212A2 (en) Systems and methods for producing efficacious regulatory t cells
KR20240007204A (ko) 키메라 항원 수용체 및 이를 포함하는 변형된 세포
CN120035658A (zh) Nkg2d工程化细胞及其组合物
WO2022221844A2 (en) Improved chimeric antigen receptors and uses thereof
KR20260013488A (ko) 면역 이펙터 세포 및 이의 용도